Literature DB >> 10617246

Changes in liver regenerative factors in a case of living-related liver transplantation.

S Eguchi1, S Okudaira, T Azuma, Y Ohno, H Fujioka, J Furui, K Tanaka, T Kanematsu.   

Abstract

Liver regeneration in a patient with fulminant hepatic failure (FHF) who underwent living-related partial liver transplantation (LRLT) was investigated regarding hepatic growth factors. The patient was a 16-yr-old Japanese male who developed severe subacute FHF. LRLT was performed using an extended left lobe of the ABO matched patient's mother. In the recipient, the pre-transplant levels of both plasma hepatocyte growth factor (HGF) and transforming growth factor (TGF)-beta were extremely high and rapidly decreased following the liver replacement. The liver volume evaluated using a CAT scan increased 195% after 2 wk in graft liver and 110% after 2 wk in the hepatectomized donor. The explanted liver (FHF liver), the liver from donor (normal liver), and the graft liver [the 3rd post-transplant day (POD 3)] were all investigated immunohistochemically. FHF liver: No liver regeneration was observed [proliferative cell nuclear antigen (PCNA) labeling index (L.I.): 0%]. In the liver, both HGF in the hepatocytes and c-met on the membrane of the hepatocytes were positive. TGF-beta was positive in the hepatocytes and no apoptosis was detected by the TUNEL method. Donor liver (POD 0): Few PCNA stained hepatocytes were detected. No HGF was detected but c-met was clearly detected on the cell membrane of the hepatocytes. Neither TGF-beta nor apoptosis was detected. Graft liver (POD 3): The PCNA L.I. was conspicuous at 40%. HGF was positive in non-parenchymal cells and c-met was positive in the cytoplasm of the hepatocytes. TGF-beta was negative while apoptosis was positive in the zone 3 hepatocytes. In conclusion, these findings suggested that the liver of the patient with FHF did not respond to liver regenerative stimulus, in part, through involvement of inhibitor TGF-beta. On POD 3, the transplanted graft was in a vigorous regenerative status in comparison to that in the hepatectomized donor. The HGF/c-met system is thought to be involved in the mechanism of regeneration. Intrahepatic apoptosis was detected in the graft on the 3rd post-transplant day probably due to transient ischemia in the liver, which was not related to the Fas/Fas-ligand system.

Entities:  

Mesh:

Year:  1999        PMID: 10617246     DOI: 10.1034/j.1399-0012.1999.130616.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

1.  Hepatitis A complicated with acute renal failure and high hepatocyte growth factor: A case report.

Authors:  Shinji Oe; Michihiko Shibata; Koichiro Miyagawa; Yuichi Honma; Masaaki Hiura; Shintaro Abe; Masaru Harada
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

2.  Safety and pharmacokinetics of recombinant human hepatocyte growth factor (rh-HGF) in patients with fulminant hepatitis: a phase I/II clinical trial, following preclinical studies to ensure safety.

Authors:  Akio Ido; Akihiro Moriuchi; Masatsugu Numata; Toshinori Murayama; Satoshi Teramukai; Hiroyuki Marusawa; Naohisa Yamaji; Hitoshi Setoyama; Il-Deok Kim; Tsutomu Chiba; Shuji Higuchi; Masayuki Yokode; Masanori Fukushima; Akira Shimizu; Hirohito Tsubouchi
Journal:  J Transl Med       Date:  2011-05-08       Impact factor: 5.531

3.  Regeneration of graft livers and limited contribution of extrahepatic cells after partial liver transplantation in humans.

Authors:  Susumu Eguchi; Mitsuhisa Takatsuki; Kosho Yamanouchi; Yukio Kamohara; Yoshitsugu Tajima; Takashi Kanematsu
Journal:  Dig Dis Sci       Date:  2009-03-19       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.